Pyrazinamide triggers degradation of its target aspartate decarboxylase
It has been shown that the bioactive component of pyrazinamide, pyrazinoic acid (POA), blocks coenzyme A biosynthesis in M. tuberculosis by binding to the aspartate decarboxylase PanD. Here the authors show that pyrazinamide triggers degradation of PanD by stimulating its degradation by the caseinol...
Guardado en:
Autores principales: | Pooja Gopal, Jickky Palmae Sarathy, Michelle Yee, Priya Ragunathan, Joon Shin, Shashi Bhushan, Junhao Zhu, Tatos Akopian, Olga Kandror, Teck Kwang Lim, Martin Gengenbacher, Qingsong Lin, Eric J. Rubin, Gerhard Grüber, Thomas Dick |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/840f3d486eeb4f43af457982724b4b9d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Chemoinformatic identification of novel inhibitors against Mycobacterium tuberculosis L-aspartate α-decarboxylase.
por: Reetu Sharma, et al.
Publicado: (2012) -
PanM, an Acetyl-Coenzyme A Sensor Required for Maturation of <sc>l</sc>-Aspartate Decarboxylase (PanD)
por: Tara N. Stuecker, et al.
Publicado: (2012) -
EFFECTS OF PYRAZINAMIDE ON PREGNANT ALBINO RATS
por: Pascale Quintino,Marisa, et al.
Publicado: (2003) -
A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide
por: Adam N. Yadon, et al.
Publicado: (2017) -
Validation of drug-like inhibitors against Mycobacterium tuberculosis L-aspartate α-decarboxylase using nuclear magnetic resonance (1H NMR).
por: Reetu Sharma, et al.
Publicado: (2012)